Hey Jane is the leading provider of telehealth abortion care, giving women access to safe and affordable care.
Today, Iris Telehealth , a leading provider of transformative behavioral health services for health systems and community healthcare organizations, announced the Acquisition of innovaTel , a division ...
Stating that we live in unprecedented times seems a bit cliche. However, cliches exist for a reason: because they’re oft ...
Blue ImpactSM grant application is open for Texas non-profits focused on improving social determinants of health. These grants and other BCBSTX community investments directly target the social and ...
The Greater Arlington Chamber of Commerce’s 2025 legislative agenda asks for various initiatives that encourage Texas’ economic growth, such as infrastructure investments, local government efficiency, ...
Victory Select , the telemedicine division of Victory Medical , is excited to announce the launch of Eros and Romeo, two innovative therapies designed to enhance male wellness. These treatments are ...
NexPhase Capital, LP ("NexPhase" or "NPC"), a thematically driven and operationally focused private equity firm, today announced the sale of SYNERGY HomeCare ("SYNERGY" or "the Company"), a leading ...
In 2024, the Sanara R&D team submitted 11 provisional patent applications covering innovations in proprietary antimicrobial technologies and hydrolyzed collagen, including novel formulations, ...
Elizabeth Taylor has been appointed to the position of Chief Financial Officer. Ms. Taylor succeeds Michael McNeil, who has been appointed to serve as Chief Accounting Officer and Chief Administrative ...
Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara,” the "Company,” "we,” "our” or "us”) (Nasdaq: SMTI), a medical technology company focused on developing and ...
As a result of these transactions, Mr. Siokas now beneficially owns 4,164,789 common shares in Cosmos Health. Greg Siokas, CEO of Cosmos Health, stated: 'I am incredibly excited about our future ...
This article does not attempt to predict the potential policies that the new administration and Congress might pursue or how ...